Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06457841
Other study ID # STUDY00018058
Secondary ID R01DA058626
Status Recruiting
Phase N/A
First received
Last updated
Start date May 9, 2024
Est. completion date July 2027

Study information

Verified date June 2024
Source University of Washington
Contact P. Priscilla Lui, Ph.D.
Phone 206-685-8391
Email pplui@uw.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Alcohol and cannabis are the most misused psychoactive substances in the United States, and their misuse among African American young adults has the potential to be especially problematic. The proposed research examines how daily and racial stressors (e.g., racism and discrimination) may lead to alcohol and cannabis use among African American young adults, and what individual and community coping and resources mitigate this causal effect. This research is designed to identify possible targets for culturally responsive prevention and treatment efforts to help prevent and reduce alcohol and cannabis use among African American young adults.


Recruitment information / eligibility

Status Recruiting
Enrollment 456
Est. completion date July 2027
Est. primary completion date July 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - Identify as Black, African American, or Afro-Caribbean - Proficient in English - Alcohol and/or cannabis use at least 4 times in past month - Endorse having used alcohol and/or cannabis to cope Exclusion Criteria: - Having participated in similar studies by the research team - Obtain cut-off scores on measures indicating possible alcohol and/or cannabis use disorder - In or seeking treatment for alcohol and/or cannabis use disorder

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Direct Discrimination
Simulated racial discrimination that is received directly from a perpetrator, commonly experienced in everyday lives by African American individuals
Vicarious Discrimination
Hearing or observing racial discrimination experienced by another person of the same racial background
Daily Hassles
Day-to-day stressors associated with school, work, finances

Locations

Country Name City State
United States Southern Methodist University Dallas Texas
United States University of Washington Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
University of Washington National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Momentary Alcohol and/or Cannabis Craving Momentary Alcohol and Cannabis Craving Scale will be administered (adapted from the Momentary Cannabis Craving Scale; Davis et al., 2024) immediately after the intervention. Mean scores will range from 1 to 7, with higher scores indicating greater momentary craving. Immediately after the intervention (i.e., within 1 minute)
Primary Duration of Alcohol and Cannabis Intoxication Self-reported number of hours of intoxication within 48 hours after the intervention 48 Hours Post-Intervention
See also
  Status Clinical Trial Phase
Completed NCT03253926 - Effect of Lorcaserin on Cannabis Withdrawal and Self-administration Phase 1/Phase 2
Completed NCT04060602 - Personalized Feedback Intervention to Reduce Risky Cannabis Use. N/A
Completed NCT01212081 - Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality
Recruiting NCT04988490 - Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes
Recruiting NCT05188404 - Aging and Marijuana: Benefits, Effects, and Risks
Completed NCT03662737 - VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Terminated NCT04436055 - Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
Active, not recruiting NCT04374773 - Effects of Pregnancy-associated Hormones on THC Metabolism in Women Phase 4
Completed NCT04316741 - Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use N/A
Recruiting NCT05396638 - Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder N/A
Recruiting NCT05309226 - Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health
Recruiting NCT03859089 - Cannabis for Opioid Substitution Trial
Recruiting NCT05849636 - Alerta Cannabis: Evaluation of Web-based Tailored Intervention N/A
Enrolling by invitation NCT05521321 - Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit N/A
Recruiting NCT05119244 - Environment and Lung Cancer N/A
Recruiting NCT04841655 - Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
Terminated NCT04100590 - Eye Tracking as a Biomarker of Cannabis Effects Phase 2
Completed NCT05167097 - Mindsets and the Effectiveness of a Brief Intervention - Replication N/A
Recruiting NCT04114903 - Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity